drugset / Trial / NCT04708821
DEXTENZA Therapy for Treatment of Allergic Conjunctivitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This prospective, open-label, single-center, randomized, investigator-sponsored clinical study seeks to compare patient-reported and clinical outcomes with DEXTENZA versus topical steroid or antihistamine treatment in patients with allergic conjunctivitis
Timeline
- Start
- 2021-04-30
- Primary completion
- 2021-09-02
- Completion
- 2021-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.4 mg | Other |
| Comparator | Loteprednol Etabonate | Other / unclassified | 0.2 % | Topical |
| Comparator | Olopatadine | Other / unclassified | 0.7 % | Topical |